Mr. Ajit Singh, chairman of Associated Capsules Group of Companies, Mumbai and Executive Committee Member of the Federation of Indian Chambers of Commerce and Industry, is also the founder official of the South Asian Pharmaceutical Excepients Council. A veteran entrepreneur, Singh is a well-known figure in the Indian pharmaceutical industry and is also actively involved with various organizations, which work on issues affecting the pharmaceutical industry. He is a member of the Scientific Committee of the Indian Herbal Pharmacoepia 2003 and also the Advisor to the US Pharmacoepia for India

Mr. D D Chopra, an industry stalwart, is presently director of Mumbai-based J B Chemicals and Pharmaceuticals Ltd. He was the chairman and managing director of Rhone Poulenc India Ltd till last year. Chopra has been actively associated with industry associations and represented on various government bodies. D D Chopra has strong fundamentals in finance and in-depth knowledge of Indian pharmaceutical market.

Mr. D G Shah, is the secretary general of Indian Pharmaceutical Alliance (IPA) comprising of eight research based Indian pharmaceutical companies. Mr Shah has been a Director with Pfizer Ltd for more than twenty years before he set up his own pharmaceutical consultancy, Vision Consultancy Group.

Mr. Devinder Pal, President, Pharmaceutical & Allied Manufacturers and Distributors Association Limited (PAMDAL) has served on many national and international forums including Indian Pharmacopoeia Committee; Drug Technical Advisory Board; Governing Body of the Bombay College of Pharmacy; Indian Institute of Packaging; OPPI; PAMDAL; and IDMA. He was the National President of the Indian Pharmaceutical Association and President of the 46th session of Indian Pharmaceutical Congress. He is the Vice President of the UK based prestigious Commonwealth Pharmaceutical Association.

Dr. Dhananjay Bakhle, is one of the top-most medical professionals in India. An expert in medico-marketing and medico-legal issues, Dr Bakhle has served reputed firms like Glaxo, Lupin and Novartis. He is currently director, medical and regulatory affairs, with Avantis Pharma.

Mr. Dilip Mehta, the former president of All India Organization of Chemists and Druggists, is a trader with a deep understanding of the pharma market. Presently, Mehta has a wide distribution network with close links with the trading community and the major pharmaceutical companies.

Dr. Gopakumar G Nair, a former president of Indian Drug Manufacturers' Association, is currently the Chairman of Intellectual Property Rights Sub-committee of IDMA. An active member of the Confederation of Indian Industry, he is also engaged in various education and training activities related to IPR.

Mr. Nihchal Israni, is one of the most successful entrepreneurs in the Indian pharma sector. Having worked with multinationals at senior positions, Israni now heads Blue Cross Labs. Mr Israni is the former president of Indian Drug Manufacturers Association.

Mr. T.S.Jaishankar, with two decades of experience in pharmaceutical industry in India is the chairman of the newly formed Confederation of Indian Pharmaceutical Industries (CIPI), an apex body for small scale drug units in India. He is also the president of the Federation of South Indian Pharmaceutical Manufacturers Association and former president of Pharmaceutical Manufacturers Association of Tamil Nadu. Mr.Jaishankar is the chairman of Chennai based Chemech Laboratories Limited, engaged in the manufacture of biological, hormones, bulk drugs and formulations. He is also the managing director of Quest Life Sciences Pvt. Ltd., a state of the art US FDA complaint clinical research organisation, with US collaboration.

Mr. Rakesh Bhargava, is Executive Vice President - Region Asia Pacific with Fresenius Kabi Germany, the world leader in the field of fluid therapy and clinical nutrition. He is currently based in Pune, India, and is also Managing Director of Fresenius Kabi India Limited. He was earlier with ICI Pharmaceuticals and Lupin ChemicalsThailand Ltd, and has been in the Pharmaceutical Industry for more than 10 years. He is Vice President of Pharmaceutical Form-Fill-Seal Association of India and has also served on the Executive Commitee of OPPI.

Mr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi. He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China in the late eighties and early nineties.

Mr. Venkat Jasti, chairman and managing director of Suven Pharma Limited is also the president, Bulk Drug Manufacturers' Association (BDMA) and vice chairman of Pharmaceutical Export Promotion Council (Pharmexcil). He also is a well-known figure in the Indian pharmaceutical industry and is actively involved with various organizations, which work on issues affecting the pharmaceutical industry.